Development of an HPLC–ICP–MS method for the determination of platinum species from new anti-tumour drugs
- 1 January 1994
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Analytical Proceedings including Analytical Communications
- Vol. 31 (10) , 295-297
- https://doi.org/10.1039/ai9943100295
Abstract
The anti-tumour drug cisplatin and some of its more modern analogues has been determined by use of a HPLC–ICP–MS system. The results compare favourably with those obtained by using HPLC–ICP–AES and HPLC–electrochemical detection and are superior to those obtained by HPLC–ETAAS.Keywords
This publication has 7 references indexed in Scilit:
- Analytical methodologies for the quantitation of platinum anti-cancer drugs and related compounds in biological mediaJournal of Pharmaceutical and Biomedical Analysis, 1990
- Analysis of platinum species originating from cis-diamminedichloroplatinum(II) (cisplatin) in human and rat plasma by high-performance liquid chromJournal of Chromatography A, 1987
- Determination of platinum-containing drugs in human plasma by liquid chromatography with reductive electrochemical detectionJournal of Chromatography A, 1987
- Application of inductively coupled plasma source mass spectrometry (ICP-MS) to the determination of trace metals in organicsJournal of Analytical Atomic Spectrometry, 1986
- High-performance liquid chromatography of platinum complexes on solvent generated anion exchangersJournal of Chromatography B: Biomedical Sciences and Applications, 1982
- Platinum Compounds: a New Class of Potent Antitumour AgentsNature, 1969